• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝胆期信号强度:LR-M 观察中具有非典型影像学特征的 HCC 诊断的一种潜在方法。

Hepatobiliary phase signal intensity: A potential method of diagnosing HCC with atypical imaging features among LR-M observations.

机构信息

Department of Radiology, Yonsei University College of Medicine, Seoul, Republic of Korea.

出版信息

PLoS One. 2021 Sep 13;16(9):e0257308. doi: 10.1371/journal.pone.0257308. eCollection 2021.

DOI:10.1371/journal.pone.0257308
PMID:34516587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8437291/
Abstract

Herein, we assessed whether hepatobiliary phase (HBP) signal intensity (SI) can be used to differentiate HCC and non-HCC malignancies within LR-M observations. 106 LR-M patients based on LI-RADS v2018 who underwent gadoxetate-disodium magnetic resonance imaging and surgery from January 2009 to December 2018 were included. SI of LR-M observation on HBP was analyzed by two radiologists and categorized into dark, low and iso-to-high groups. Tumor was classified as dark when more than 50% of tumor showed hypointensity compared to spleen, as low when more than 50% of tumor showed hyperintensity compared to spleen but hypointensity compared to liver parenchyma, and as iso-to-high if there was even a focal iso-intensity or hyperintensity compared to liver parenchyma. Analysis of clinicopathological factors and association between imaging and histology was performed. Out of 106 LR-M, 42 (40%) were showed dark, 61 (58%) showed low, and 3 (3%) showed iso-to-high SI in HBP. Three iso-to-high SI LR-M were HCCs (P = 0.060) and their major histologic differentiation was Edmondson grade 1 (P = 0.001). 43 out of 61 (71%) low SI LR-M were iCCA or cHCC-CCA (P = 0.002). Inter-reader agreement of HBP SI classification was excellent, with a kappa coefficient of 0.872. LR-M with iso-to-high SI in HBP is prone to being HCC while LR-M with low SI in HBP is prone to being tumor with fibrous stroma such as iCCA and cHCC-CCA. Classification of LR-M based on HBP SI may be a helpful method of differentiating HCC from non-HCC malignancies.

摘要

在此,我们评估了肝胆期(HBP)信号强度(SI)是否可用于区分 LR-M 观察中的 HCC 和非 HCC 恶性肿瘤。纳入了 2009 年 1 月至 2018 年 12 月期间根据 LI-RADS v2018 接受钆塞酸二钠磁共振成像和手术的 106 例 LR-M 患者。由两位放射科医生分析 LR-M 观察在 HBP 上的 SI,并将其分为暗、低和等至高组。当与脾脏相比,肿瘤超过 50%的区域显示为低信号强度时,肿瘤被归类为暗;当与脾脏相比,肿瘤超过 50%的区域显示为高信号强度,但与肝实质相比显示为低信号强度时,肿瘤被归类为低;当与肝实质相比存在局灶性等信号强度或高信号强度时,肿瘤被归类为等至高。对临床病理因素和影像学与组织学之间的关联进行了分析。在 106 例 LR-M 中,42 例(40%)显示 HBP 为暗,61 例(58%)显示低,3 例(3%)显示等至高 SI。3 例等至高 SI 的 LR-M 为 HCC(P = 0.060),其主要组织学分化为 Edmondson 分级 1(P = 0.001)。61 例低 SI 的 LR-M 中,43 例(71%)为 iCCA 或 cHCC-CCA(P = 0.002)。HBP SI 分类的两位观察者之间的一致性极好,kappa 系数为 0.872。HBP 呈等至高 SI 的 LR-M 倾向于 HCC,而 HBP 呈低 SI 的 LR-M 倾向于纤维基质肿瘤,如 iCCA 和 cHCC-CCA。基于 HBP SI 的 LR-M 分类可能是区分 HCC 和非 HCC 恶性肿瘤的一种有用方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/750a/8437291/a4fe8951b250/pone.0257308.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/750a/8437291/ed38c27a1351/pone.0257308.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/750a/8437291/109dde75a95d/pone.0257308.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/750a/8437291/32ac0e4259ce/pone.0257308.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/750a/8437291/a4fe8951b250/pone.0257308.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/750a/8437291/ed38c27a1351/pone.0257308.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/750a/8437291/109dde75a95d/pone.0257308.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/750a/8437291/32ac0e4259ce/pone.0257308.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/750a/8437291/a4fe8951b250/pone.0257308.g004.jpg

相似文献

1
Hepatobiliary phase signal intensity: A potential method of diagnosing HCC with atypical imaging features among LR-M observations.肝胆期信号强度:LR-M 观察中具有非典型影像学特征的 HCC 诊断的一种潜在方法。
PLoS One. 2021 Sep 13;16(9):e0257308. doi: 10.1371/journal.pone.0257308. eCollection 2021.
2
Diagnostic performance of LI-RADS version 2018 in differentiating hepatocellular carcinoma from other hepatic malignancies in patients with hepatitis B virus infection.LI-RADS 版本 2018 诊断性能在乙型肝炎病毒感染患者中区分肝细胞癌与其他肝脏恶性肿瘤。
Bosn J Basic Med Sci. 2020 Aug 3;20(3):401-410. doi: 10.17305/bjbms.2019.4576.
3
The role of lesion hypointensity on gadobenate dimeglumine-enhanced hepatobiliary phase MRI as an additional major imaging feature for HCC classification using LI-RADS v2018 criteria.钆贝葡胺增强肝胆期 MRI 病变低信号强度在 LI-RADS v2018 标准中作为 HCC 分类的另一个主要影像学特征的作用。
Eur Radiol. 2021 Oct;31(10):7715-7724. doi: 10.1007/s00330-021-07807-y. Epub 2021 Mar 29.
4
Liver Imaging Reporting and Data System (LI-RADS) v2018: diagnostic value of ancillary features favoring malignancy in hypervascular observations ≥ 10 mm at intermediate (LR-3) and high probability (LR-4) for hepatocellular carcinoma.肝脏影像报告和数据系统 (LI-RADS) v2018:在中间 (LR-3) 和高概率 (LR-4) 水平下,≥ 10 毫米的富血管性观察中辅助特征有利于肝癌的诊断价值。
Eur Radiol. 2020 Jul;30(7):3770-3781. doi: 10.1007/s00330-020-06698-9. Epub 2020 Feb 27.
5
Differentiation of hepatocellular carcinoma from intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in high-risk patients matched to MR field strength: diagnostic performance of LI-RADS version 2018.在与磁共振场强匹配的高危患者中,鉴别肝细胞癌、肝内胆管细胞癌和肝细胞-胆管细胞癌:LI-RADS 版本 2018 的诊断性能。
Abdom Radiol (NY). 2021 Jul;46(7):3168-3178. doi: 10.1007/s00261-021-02996-y. Epub 2021 Mar 3.
6
How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI?如何利用 LI-RADS 的 LR-M 特征提高钆塞酸增强 MRI 诊断混合细胞型肝癌?
Eur Radiol. 2019 May;29(5):2408-2416. doi: 10.1007/s00330-018-5893-1. Epub 2018 Dec 14.
7
Liver imaging reporting and data system (LI-RADS) v2018: comparison between computed tomography and gadoxetic acid-enhanced magnetic resonance imaging.肝脏影像报告和数据系统(LI-RADS)v2018:计算机断层扫描与钆塞酸增强磁共振成像的比较。
Jpn J Radiol. 2019 Sep;37(9):651-659. doi: 10.1007/s11604-019-00855-x. Epub 2019 Jul 18.
8
Incorporation of Ancillary MRI Features Into the LI-RADS Treatment Response Algorithm: Impact on Diagnostic Performance After Locoregional Treatment of Hepatocellular Carcinoma.将辅助 MRI 特征纳入 LI-RADS 治疗反应算法:对肝细胞癌局部治疗后诊断性能的影响。
AJR Am J Roentgenol. 2022 Mar;218(3):484-493. doi: 10.2214/AJR.21.26677. Epub 2021 Sep 29.
9
Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System (LI-RADS) in gadoxetate-enhanced MRI.前瞻性应用肝脏成像报告和数据系统(LI-RADS)在钆塞酸增强 MRI 中的诊断准确性。
Eur Radiol. 2018 May;28(5):2038-2046. doi: 10.1007/s00330-017-5188-y. Epub 2017 Dec 11.
10
LI-RADS M (LR-M) criteria and reporting algorithm of v2018: diagnostic values in the assessment of primary liver cancers on gadoxetic acid-enhanced MRI.LI-RADS M (LR-M) 标准和 v2018 版报告算法:钆塞酸增强 MRI 评估原发性肝癌的诊断价值。
Abdom Radiol (NY). 2020 Aug;45(8):2440-2448. doi: 10.1007/s00261-020-02545-z.

引用本文的文献

1
Radiologic and Pathologic Insights in Combined Hepatocellular-Cholangiocarcinoma: A Report of Three Cases.肝细胞-胆管细胞癌的影像学与病理学见解:三例报告
Reports (MDPI). 2025 Aug 8;8(3):142. doi: 10.3390/reports8030142.
2
Effect of body mass index (BMI) on image contrast in the hepatobiliary phase of Gd-EOB-DTPA-enhanced-MRI and the feasibility of the application of half-dose Gd-EOB-DTPA to hepatobiliary phase imaging in patients with a BMI less than 24: a comparative study.体重指数(BMI)对钆塞酸二钠增强磁共振成像(Gd-EOB-DTPA-enhanced-MRI)肝胆期图像对比度的影响以及半剂量钆塞酸二钠应用于BMI小于24的患者进行肝胆期成像的可行性:一项对比研究
Quant Imaging Med Surg. 2023 Sep 1;13(9):6176-6192. doi: 10.21037/qims-23-653. Epub 2023 Jul 21.
3

本文引用的文献

1
Deep learning-assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver.深度学习辅助在肝脏对比增强磁共振成像(MRI)上鉴别经病理证实的非典型和典型肝细胞癌(HCC)与非HCC。
Eur Radiol. 2021 Jul;31(7):4981-4990. doi: 10.1007/s00330-020-07559-1. Epub 2021 Jan 6.
2
Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features.钆塞酸增强 MRI 上 LI-RADS M 病变的诊断:通过血清标志物和影像学特征识别含胆管癌的肿瘤。
Eur Radiol. 2021 Jun;31(6):3638-3648. doi: 10.1007/s00330-020-07488-z. Epub 2020 Nov 27.
3
Imaging prognostication and tumor biology in hepatocellular carcinoma.肝细胞癌的影像学预后评估与肿瘤生物学
J Liver Cancer. 2023 Sep;23(2):284-299. doi: 10.17998/jlc.2023.08.29. Epub 2023 Sep 15.
Gadoxetic acid-enhanced MRI of hepatocellular carcinoma: Diagnostic performance of category-adjusted LR-5 using modified criteria.
钆塞酸增强 MRI 对肝细胞癌的诊断性能:使用改良标准的类别调整后的 LR-5 的诊断表现。
PLoS One. 2020 Nov 13;15(11):e0242344. doi: 10.1371/journal.pone.0242344. eCollection 2020.
4
LI-RADS M (LR-M) criteria and reporting algorithm of v2018: diagnostic values in the assessment of primary liver cancers on gadoxetic acid-enhanced MRI.LI-RADS M (LR-M) 标准和 v2018 版报告算法:钆塞酸增强 MRI 评估原发性肝癌的诊断价值。
Abdom Radiol (NY). 2020 Aug;45(8):2440-2448. doi: 10.1007/s00261-020-02545-z.
5
Diagnostic performance of the LR-M criteria and spectrum of LI-RADS imaging features among primary hepatic carcinomas.LR-M 标准与原发性肝癌 LI-RADS 成像特征谱的诊断性能。
Abdom Radiol (NY). 2020 Nov;45(11):3743-3754. doi: 10.1007/s00261-020-02562-y.
6
Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular Cholangiocarcinoma: Working Group Report From the ILTS Transplant Oncology Consensus Conference.肝移植治疗胆管细胞癌和混合型肝细胞胆管细胞癌:ILTS 移植肿瘤学共识会议工作组报告。
Transplantation. 2020 Jun;104(6):1125-1130. doi: 10.1097/TP.0000000000003212.
7
Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging.第八届国际肝脏磁共振成像论坛共识报告。
Eur Radiol. 2020 Jan;30(1):370-382. doi: 10.1007/s00330-019-06369-4. Epub 2019 Aug 5.
8
LI-RADS: Diagnostic Performance of Hepatobiliary Phase Hypointensity and Major Imaging Features of LR-3 and LR-4 Lesions Measuring 10-19 mm With Arterial Phase Hyperenhancement.LI-RADS:动脉期高增强且测量直径为 10-19mm 的 LR-3 和 LR-4 病变肝胆期低信号的诊断性能及主要影像学特征。
AJR Am J Roentgenol. 2019 Aug;213(2):W57-W65. doi: 10.2214/AJR.18.20979. Epub 2019 Apr 30.
9
Hepatocellular Carcinoma versus Other Hepatic Malignancy in Cirrhosis: Performance of LI-RADS Version 2018.肝硬化中肝细胞癌与其他肝脏恶性肿瘤的比较:LI-RADS 版本 2018 的表现。
Radiology. 2019 Apr;291(1):72-80. doi: 10.1148/radiol.2019181995. Epub 2019 Jan 29.
10
Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers.钆塞酸增强磁共振成像:肝细胞癌及类似病变。
Clin Mol Hepatol. 2019 Sep;25(3):223-233. doi: 10.3350/cmh.2018.0107. Epub 2019 Jan 21.